Stock Analiz

PMGC Holdings Inc. ELAB

Biotechnology: Pharmaceutical Preparations · IPO 2023 · data as of November 13, 2026

$1.58Market cap $1M
Open the interactive analysis →

PMGC Holdings Inc. (ELAB) is a healthcare company listed in the US with a market value of about $1M. In the twelve months to September 30, 2026 it had revenue of $5M and net income of -$13M, a net margin of -275.7%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -76%.

About PMGC

PMGC is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2023. Revenue went from $766277 in 2022 to $590084 in 2025, a decline of about 8.3% a year. It was profitable in 0 of the last 4 years in our data. Its share count rose by 25027% over three years (dilution for shareholders). It spends 25% of revenue on research and development.

Score: 0.6 / 5

Value0/5
Future growth0/5
Track record0/5
Financial health2/5
Shareholder returns1/5

Checks passed

  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.3
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-783.4%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-599.7%
ROIC (5-yr avg.)-75.5%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 4 years

Fiscal yearTTM2025202420232022
Revenue$5M$590084—$2M$766277
Net income-$13M-$8M-$6M-$4M-$2M
Free cash flow-$10M-$6M-$5M-$5M—
EPS (diluted)$-16.33$-9.56$-105.99$-1176.45$-555.87
Net margin-275.7%-1313.0%—-251.2%-234.9%
ROIC—-64.1%—-62.4%-100.0%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does PMGC pay a dividend?

Not currently.

Is PMGC a good stock to buy?

We do not give buy or sell advice. PMGC scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.